The loss of function of p53 can also be related to an increased expression of negative regulators, such as MDMX and MDM2, which are highly expressed in PCa tumor samples derived from patients with CRPC [80] (reviewed in [81]). This evidence concerns the gene TP53 and posterior cortical atrophy.